Medical and Dental Consultantsí Association of Nigeria
Home - About us - Editorial board - Search - Ahead of print - Current issue - Archives - Submit article - Instructions - Subscribe - Advertise - Contacts - Login 
  Users Online: 790   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Year : 2009  |  Volume : 12  |  Issue : 1  |  Page : 108-112

Concurrent use of cyclophosphamide and prednisolone in childhood nephrotic syndrome in South-East Nigeria; a report of 5 cases

Department of Paediatrics, University of Nigeria Teaching Hospital, Enugu, Nigeria

Correspondence Address:
E O Obidike
Department of Paediatrics, University of Nigeria Teaching Hospital, Enugu, Nigeria

Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 19562934

Rights and PermissionsRights and Permissions

INTRODUCTION: Nephrotic syndrome is a chronic renal disease that can lead to end stage renal disease. There are different histological types with global variations in frequency. Literatures reviewed showed that the African variant is less likely to be minimal change variant. No clear treatment protocol for it has been most beneficial. OBJECTIVE: This paper aims to evaluate the outcome of a treatment protocol using cyclophosphamide and prednisolone concurrently. METHODS: A low dose and short duration concurrent use of cyclophosphamide and prednisolone was used for treating children with nephrotic syndrome who had not developed derangements of their renal function. The case files of those that were treated and followed up over a 10 year period or until they were above 18 years of age were analysed for their clinical parameters. RESULTS: Five cases were treated and all have been in clinical remission for more than 4 years as at the time of the review, though 2 of them relapsed twice initially. They were all aged above 6 years and had microscopic hematuria. The 3 cases whose ESRs were done had high levels. Two cases that presented 1 yr after the onset of their symptoms resolved without relapse while 2 out of the remaining 3 in whom this interval was less than 6 months relapsed. CONCLUSION: This treatment protocol appears beneficial to childhood nephrotics in this environment and should be used.

[PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal